TY - JOUR
T1 - Nigerooligosaccharides augments natural killer activity of hepatic mononuclear cells in mice
AU - Murosaki, Shinji
AU - Muroyama, Koutarou
AU - Yamamoto, Yoshihiro
AU - Liu, Tiei
AU - Yoshikai, Yasunobu
PY - 2002/1/1
Y1 - 2002/1/1
N2 - Nigerooligosaccharides (NOS), a mixture of nigerose and nigerosylmaltooligosaccharides, is immunopotentiating oligosaccharides found in foodstuffs. Augmentation of natural killer (NK) activity by NOS was studied in vitro and in vivo in mice. In vitro treatment of hepatic mononuclear cells (MNC) from normal mice with 1 μg/ml NOS 17 h or just prior to the cytotoxicity assay enhanced their cytotoxicity against YAC-1 cells. NK activity of hepatic MNC was also enhanced in mice injected intraperitoneally with 0.4 mg NOS or in mice given 1% NOS solution orally as a drinking fluid. In association with the augmentation of NK activity, increase in the liver weight induced by intravenous inoculation of EL-4 tumor cells was significantly suppressed by intraperitoneal pretreatment with 0.4 mg NOS. Moreover, drinking 1% NOS significantly improved the survival curve of mice intravenously inoculated with EL-4 cells. Our results suggest that the immunopotentiating activity of NOS is exerted partly through the augmentation of NK activity.
AB - Nigerooligosaccharides (NOS), a mixture of nigerose and nigerosylmaltooligosaccharides, is immunopotentiating oligosaccharides found in foodstuffs. Augmentation of natural killer (NK) activity by NOS was studied in vitro and in vivo in mice. In vitro treatment of hepatic mononuclear cells (MNC) from normal mice with 1 μg/ml NOS 17 h or just prior to the cytotoxicity assay enhanced their cytotoxicity against YAC-1 cells. NK activity of hepatic MNC was also enhanced in mice injected intraperitoneally with 0.4 mg NOS or in mice given 1% NOS solution orally as a drinking fluid. In association with the augmentation of NK activity, increase in the liver weight induced by intravenous inoculation of EL-4 tumor cells was significantly suppressed by intraperitoneal pretreatment with 0.4 mg NOS. Moreover, drinking 1% NOS significantly improved the survival curve of mice intravenously inoculated with EL-4 cells. Our results suggest that the immunopotentiating activity of NOS is exerted partly through the augmentation of NK activity.
UR - http://www.scopus.com/inward/record.url?scp=0035179829&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035179829&partnerID=8YFLogxK
U2 - 10.1016/S1567-5769(01)00152-7
DO - 10.1016/S1567-5769(01)00152-7
M3 - Article
C2 - 11789666
AN - SCOPUS:0035179829
SN - 1567-5769
VL - 2
SP - 151
EP - 159
JO - International Immunopharmacology
JF - International Immunopharmacology
IS - 1
ER -